These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 11583754

  • 1. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ratjen F, Döring G, Nikolaizik WH.
    Lancet; 2001 Sep 22; 358(9286):983-4. PubMed ID: 11583754
    [Abstract] [Full Text] [Related]

  • 2. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL.
    J Infect Dis; 1999 May 22; 179(5):1190-6. PubMed ID: 10191222
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.
    Clin Microbiol Infect; 2005 Sep 22; 11(9):690-703. PubMed ID: 16104983
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis.
    Stanojevic S, Waters V, Mathew JL, Taylor L, Ratjen F.
    J Cyst Fibros; 2014 Mar 22; 13(2):172-8. PubMed ID: 24091166
    [Abstract] [Full Text] [Related]

  • 5. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG, Gembitskaia TE.
    Ter Arkh; 2010 Mar 22; 82(8):76-8. PubMed ID: 20873251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
    Wiesemann HG, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, Döring G, von der Hardt H.
    Pediatr Pulmonol; 1998 Feb 22; 25(2):88-92. PubMed ID: 9516091
    [Abstract] [Full Text] [Related]

  • 9. Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.
    Woodward TC, Brown R, Sacco P, Zhang J.
    J Med Econ; 2010 Feb 22; 13(3):492-9. PubMed ID: 20670159
    [Abstract] [Full Text] [Related]

  • 10. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
    Quintana-Gallego E, Lopez-Campos JL, Calero C, Dapena FJ.
    Med Clin (Barc); 2014 Jan 21; 142(2):59-63. PubMed ID: 23369499
    [Abstract] [Full Text] [Related]

  • 11. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM, Waugh J, Noble S.
    Drugs; 2003 Jan 21; 63(22):2501-20. PubMed ID: 14609360
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Proesmans M, Vermeulen F, Boulanger L, Verhaegen J, De Boeck K.
    J Cyst Fibros; 2013 Jan 21; 12(1):29-34. PubMed ID: 22762867
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
    Taccetti G, Repetto T, Procopio E, Farina S, Campana S.
    Lancet; 2002 Feb 16; 359(9306):625-6. PubMed ID: 11867138
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Gappa M, Steinkamp G, Tümmler B, von der Hardt H.
    Scand J Gastroenterol Suppl; 1988 Feb 16; 143():74-6. PubMed ID: 3164515
    [Abstract] [Full Text] [Related]

  • 19. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D, Henig N, Morrissey B, Gotfried M.
    Chest; 2006 Nov 16; 130(5):1503-10. PubMed ID: 17099030
    [Abstract] [Full Text] [Related]

  • 20. Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution.
    Sawicki GS, Signorovitch JE, Zhang J, Latremouille-Viau D, von Wartburg M, Wu EQ, Shi L.
    Pediatr Pulmonol; 2012 Jan 16; 47(1):44-52. PubMed ID: 21815282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.